Comment on "Chemotherapy-Induced Left Ventricular Dysfunction in Patients with Breast Cancer".
作者信息
Altundag Kadri
机构信息
Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.
出版信息
J Breast Cancer. 2017 Mar;20(1):112-113. doi: 10.4048/jbc.2017.20.1.112. Epub 2017 Mar 24.
Abstract
摘要
相似文献
1
Comment on "Chemotherapy-Induced Left Ventricular Dysfunction in Patients with Breast Cancer".关于“乳腺癌患者化疗所致左心室功能障碍”的评论
J Breast Cancer. 2017 Mar;20(1):112-113. doi: 10.4048/jbc.2017.20.1.112. Epub 2017 Mar 24.
2
Chemotherapy-Induced Left Ventricular Dysfunction in Patients with Breast Cancer.乳腺癌患者化疗所致左心室功能障碍
J Breast Cancer. 2016 Dec;19(4):402-409. doi: 10.4048/jbc.2016.19.4.402. Epub 2016 Dec 23.
3
Effect of Rosuvastatin in Preventing Chemotherapy-Induced Cardiotoxicity in Women With Breast Cancer: A Randomized, Single-Blind, Placebo-Controlled Trial.罗苏伐他汀预防乳腺癌女性化疗相关性心脏毒性的效果：一项随机、单盲、安慰剂对照试验。
J Cardiovasc Pharmacol Ther. 2019 May;24(3):233-241. doi: 10.1177/1074248418821721. Epub 2019 Jan 2.
4
Left ventricular systolic function in HER2/neu negative breast cancer patients treated with anthracycline chemotherapy: a comparative analysis of left ventricular ejection fraction and myocardial strain imaging over 12 months.曲妥珠单抗阴性的 HER2/neu 乳腺癌患者接受蒽环类化疗后的左心室收缩功能：左心室射血分数和心肌应变成像 12 个月的对比分析。
Eur J Cancer. 2013 Nov;49(16):3396-403. doi: 10.1016/j.ejca.2013.06.046. Epub 2013 Aug 9.
5
Ventricular-Arterial Coupling in Breast Cancer Patients After Treatment With Anthracycline-Containing Adjuvant Chemotherapy.接受含蒽环类辅助化疗的乳腺癌患者的心室-动脉耦合
Oncologist. 2016 Feb;21(2):141-9. doi: 10.1634/theoncologist.2015-0352. Epub 2016 Jan 13.
6
Cardiotoxicity in breast cancer treatment: What about left ventricular diastolic function and left atrial function?乳腺癌治疗中的心脏毒性：左心室舒张功能和左心房功能如何？
Echocardiography. 2019 Oct;36(10):1806-1813. doi: 10.1111/echo.14487. Epub 2019 Oct 1.
7
Long-term outcome of cardiac function in a population-based cohort of breast cancer survivors: A cross-sectional study.基于人群的乳腺癌幸存者心脏功能的长期预后：一项横断面研究。
Eur J Cancer. 2017 Aug;81:56-65. doi: 10.1016/j.ejca.2017.05.013. Epub 2017 Jun 8.
8
Left Ventricular Systolic Dysfunction Predicted By Early Troponin I Release After Anthracycline Based Chemotherapy In Breast Cancer Patients.蒽环类药物化疗后早期肌钙蛋白I释放预测乳腺癌患者左心室收缩功能障碍
J Ayub Med Coll Abbottabad. 2017 Apr-Jun;29(2):266-269.
9
Assessment of early epirubicin cardiotoxicity in women with breast cancer.乳腺癌女性患者早期表柔比星心脏毒性的评估
Anticancer Res. 1997 Sep-Oct;17(5B):3889-91.
10
Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer.二维斑点追踪超声心动图预测乳腺癌患者接受蒽环类药物-曲妥珠单抗化疗相关的早期亚临床心脏毒性。
BMC Cancer. 2018 Oct 25;18(1):1037. doi: 10.1186/s12885-018-4935-z.
本文引用的文献
1
Role of Troponins I and T and N-Terminal Prohormone of Brain Natriuretic Peptide in Monitoring Cardiac Safety of Patients With Early-Stage Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Trastuzumab: A Herceptin Adjuvant Study Cardiac Marker Substudy.肌钙蛋白 I 和 T 及脑钠肽 N 端前体在监测早期人表皮生长因子受体 2 阳性乳腺癌接受曲妥珠单抗治疗患者心脏安全性中的作用：赫赛汀辅助研究心脏标志物子研究。
J Clin Oncol. 2017 Mar 10;35(8):878-884. doi: 10.1200/JCO.2015.65.7916. Epub 2016 Oct 23.
2
Chemotherapy-Induced Left Ventricular Dysfunction in Patients with Breast Cancer.乳腺癌患者化疗所致左心室功能障碍
J Breast Cancer. 2016 Dec;19(4):402-409. doi: 10.4048/jbc.2016.19.4.402. Epub 2016 Dec 23.
3
Baseline Immunoglobulin E Levels as a Marker of Doxorubicin- and Trastuzumab-Associated Cardiac Dysfunction.基线免疫球蛋白E水平作为多柔比星和曲妥珠单抗相关心脏功能障碍的标志物
Circ Res. 2016 Oct 28;119(10):1135-1144. doi: 10.1161/CIRCRESAHA.116.309004. Epub 2016 Aug 31.
4
Trastuzumab-associated cardiac events at 8 years of median follow-up in the Herceptin Adjuvant trial (BIG 1-01).曲妥珠单抗辅助治疗 8 年的中位随访时发生的心脏不良事件：赫赛汀辅助治疗研究（BIG 1-01）。
J Clin Oncol. 2014 Jul 10;32(20):2159-65. doi: 10.1200/JCO.2013.53.9288. Epub 2014 Jun 9.
Zotero 插件